Immune-mediated comorbidities in Saudi patients with narcolepsy
Majed Alomar,1 Aljohara S Almeneessier,1,2 Awad H Olaish,1 Abdulrahman Alshiban,1 Abdullah Alomar,1 Ahmed S BaHammam1,31The University Sleep Disorders Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Family and Community Medicine Department, College o...
Guardado en:
Autores principales: | Alomar M, Almeneessier AS, Olaish AH, Alshiban A, Alomar A, BaHammam AS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55b1420d05e744bd879797f19b24a3a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns
por: Barker EC, et al.
Publicado: (2020) -
Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD
por: Wang YG, et al.
Publicado: (2017) -
Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
por: Pellitteri G, et al.
Publicado: (2020) -
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
por: Swick TJ
Publicado: (2015) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021)